1. France Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 89
Price: Single User License – US$2500
France Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “France Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the France Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the France Diabetes Care
Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi, Novo
Nordisk A/S, LifeScan, Inc., Medtronic, Inc. and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197488-france-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In France 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices Market, France, Revenue Mix ($m), 2011 12
3.4 Diabetes Care Devices Market, France, Category Contribution (%), 2011 13
3.5 Diabetes Care Devices, France, Company Share (2010-2011) 19
4 Glucose Monitoring In France 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, France, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, France, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 32
4.5.1 Blood Glucose Meters, Volume (2004-2018) 34
4.6 Glucose Monitoring Average Price (2004-2018) 36
4.7 Glucose Monitoring Distribution Share (2010-2011) 37
4.8 Glucose Monitoring, France, Company Share (2010-2011) 38
5 Insulin Delivery In France 40
5.1 Insulin Delivery, Market Segmentation 40
5.2 Insulin Delivery Market, France, Revenue Mix ($m), 2011 41

3. 5.3 Insulin Delivery Market, France, Segment Contribution (%), 2011 42
5.4 Insulin Delivery Overall Revenue, (2004-2018) 43
5.4.1 Insulin Pens, Revenue (2004-2018) 47
5.4.2 Insulin Pumps, Revenue (2004-2018) 51
5.5 Insulin Delivery Overall Volume (2004-2018) 55
5.5.1 Insulin Pens, Volume (2004-2018) 58
5.5.2 Insulin Pumps, Volume (2004-2018) 60
5.6 Insulin Delivery Average Price (2004-2018) 64
5.7 Insulin Delivery Distribution Share (2010-2011) 65
5.8 Insulin Delivery, France, Company Share (2010-2011) 66
6 Overview of Key Companies in France Diabetes Care Devices Market 68
6.1 F. Hoffmann-La Roche Ltd. 68
6.1.1 Company Overview 68
6.1.2 Share in the France Diabetes Care Devices Market 68
6.2 Eli Lilly and Company 69
6.2.1 Company Overview 69
6.2.2 Share in the France Diabetes Care Devices Market 69
6.3 Sanofi 70
6.3.1 Company Overview 70
6.3.2 Share in the France Diabetes Care Devices Market 70
6.4 Novo Nordisk A/S 71
6.4.1 Company Overview 71
6.4.2 Share in the France Diabetes Care Devices Market 71
6.5 LifeScan, Inc. 72
6.5.1 Company Overview 72
6.5.2 Share in the France Diabetes Care Devices Market 72
6.6 Medtronic, Inc. 73
6.6.1 Company Overview 73
6.6.2 Share in the France Diabetes Care Devices Market 73
6.7 Bayer HealthCare AG 74
6.7.1 Company Overview 74
6.8 Abbott Laboratories 74
6.8.1 Company Overview 74
6.9 Becton, Dickinson and Company 75
6.9.1 Company Overview 75
6.10 Animas Corporation 75
6.10.1 Company Overview 75
6.11 Ypsomed Holding AG 75
6.11.1 Company Overview 75
6.12 ARKRAY, Inc. 76
6.12.1 Company Overview 76
6.13 Terumo Corporation 76

4. 6.13.1 Company Overview 76
6.14 B. Braun Melsungen AG 77
6.14.1 Company Overview 77
6.15 Nipro Corporation 77
6.15.1 Company Overview 77
7 Diabetes Care Devices Market Pipeline Products 78
8 Financial Deals Landscape 82
8.1 Partnerships 82
8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 82
9 Recent Developments 83
9.1 Strategy And Business Planning 83
9.1.1 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 83
9.2 Product News 83
9.2.1 Feb 14, 2008: Sanofi-aventis’ SoloSTAR Insulin Pen For Lantus And Apidra Receives The
GOOD DESIGN Award 83
10 Appendix 84
10.1 Definitions of Markets Covered in the Report 85
10.1.1 Diabetes Care Devices 85
10.2 Research Methodology 87
10.3 Secondary Research 87
10.4 Primary Research 88
10.5 Models 88
10.6 Forecasts 88
10.7 Expert Panels 89
10.8 GlobalData Consulting 89
10.9 Currency Conversion 89
10.10 Contact Us 89
10.11 Disclaimer 89
1.1 List of Tables
Table 1: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 11
Table 2: Diabetes Care Devices Market, France, Category Contribution (%), 2011 13
Table 3: Diabetes Care Devices, France, Cross-Segment Analysis, 2004-2018 15
Table 4: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Table 5: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 18
Table 6: Diabetes Care Devices, France, Company Share by Revenue ($m), USD Constant, 2010-
2011 20
Table 7: Glucose Monitoring Market, France, Segment Contribution (%), 2011 23
Table 8: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 25

5. Table 9: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 27
Table 10: Blood Glucose Meters, France, Revenue ($m*) USD Constant, by Sub-Segment,
Historic, 2004-2011 29
Table 11: Blood Glucose Meters, France, Revenue ($m*) USD Constant, by Sub-Segment,
Forecast, 2011-2018 31
Table 12: Glucose Monitoring, France, Volume (Units) by Segment, Historic, 2004-2011 32
Table 13: Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2011-2018 33
Table 14: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 34
Table 15: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018
35
Table 16: Glucose Monitoring, France, Average Price ($), Historic, 2004-2011 36
Table 17: Glucose Monitoring, France, Average Price ($), Forecast, 2011-2018 36
Table 18: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 37
Table 19: Glucose Monitoring, France, Company Share by Revenue ($m), USD Constant, 2010-
2011 39
Table 20: Insulin Delivery Market, France, Segment Contribution (%), 2011 42
Table 21: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
44
Table 22: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 46
Table 23: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 48
Table 24: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 50
Table 25: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 52
Table 26: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 54
Table 27: Insulin Delivery, France, Volume (Units) by Segment, Historic, 2004-2011 56
Table 28: Insulin Delivery, France, Volume (Units) by Segment, Forecast, 2011-2018 57
Table 29: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 58
Table 30: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59
Table 31: Insulin Pumps, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 61
Table 32: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63
Table 33: Insulin Delivery, France, Average Price ($), Historic, 2004-2011 64
Table 34: Insulin Delivery, France, Average Price ($), Forecast, 2011-2018 64
Table 35: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 65
Table 36: Insulin Delivery, France, Company Share by Revenue ($m), USD Constant, 2010-2011
67

6. Table 37: Diabetes Care Devices Market Pipeline Products 78
Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 82
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices Market, France, Revenue Mix ($m), 2011 12
Figure 4: Diabetes Care Devices Market, France, Category Contribution (%), 2011 13
Figure 5: Diabetes Care Devices, France, Cross-Segment Analysis, 2004-2018 14
Figure 6: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Figure 7: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 17
Figure 8: Diabetes Care Devices, France, Company Share (%)-2011 19
Figure 9: Glucose Monitoring, Market Segmentation 21
Figure 10: Glucose Monitoring Market, France, Revenue Mix ($m), 2011 22
Figure 11: Glucose Monitoring Market, France, Segment Contribution (%), 2011 23
Figure 12: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 24
Figure 13: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 26
Figure 14: Blood Glucose Meters, France, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 28
Figure 15: Blood Glucose Meters, France, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 30
Figure 16: Glucose Monitoring, France, Volume (Units) by Segment, Historic, 2004-2011 32
Figure 17: Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2011-2018 33
Figure 18: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Historic, 2004-2011
34
Figure 19: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018
35
Figure 20: Glucose Monitoring, France, Company Share (%), 2011 38
Figure 21: Insulin Delivery, Market Segmentation 40
Figure 22: Insulin Delivery Market, France, Revenue Mix ($m), 2011 41
Figure 23: Insulin Delivery Market, France, Segment Contribution (%), 2011 42
Figure 24: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 43
Figure 25: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 45
Figure 26: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 47
Figure 27: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-

7. 2018 49
Figure 28: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 51
Figure 29: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 53
Figure 30: Insulin Delivery, France, Volume (Units) by Segment, Historic, 2004-2011 55
Figure 31: Insulin Delivery, France, Volume (Units) by Segment, Forecast, 2011-2018 57
Figure 32: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 58
Figure 33: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59
Figure 34: Insulin Pumps, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 60
Figure 35: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62
Figure 36: Insulin Delivery, France, Company Share (%), 2011 66
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),France Diabetes Care Devices
Market, 2011 68
Figure 38: Eli Lilly and Company, Company Share (%),France Diabetes Care Devices Market,
2011 69
Figure 39: Sanofi, Company Share (%),France Diabetes Care Devices Market, 2011 70
Figure 40: Novo Nordisk A/S, Company Share (%),France Diabetes Care Devices Market, 2011
71
Figure 41: LifeScan, Inc., Company Share (%),France Diabetes Care Devices Market, 2011 72
Figure 42: Medtronic, Inc., Company Share (%),France Diabetes Care Devices Market, 2011 73
Contact: sales@reportsandreports.com for more information.